BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9476757)

  • 1. Does the chronological relationship between the onset of dysthymia and major depression influence subsequent response to antidepressants?
    Levitt AJ; Joffe RT; Sokolov ST
    J Affect Disord; 1998 Jan; 47(1-3):169-75. PubMed ID: 9476757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity of dysthymia to predict clinical depressive symptoms as measured by the Hamilton Depression Scale at the 5-year follow-up of patients with first episode depression.
    Bech P; Kessing LV; Bukh JD
    Nord J Psychiatry; 2016 Nov; 70(8):563-6. PubMed ID: 27181030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The undertreatment of dysthymia.
    Shelton RC; Davidson J; Yonkers KA; Koran L; Thase ME; Pearlstein T; Halbreich U
    J Clin Psychiatry; 1997 Feb; 58(2):59-65. PubMed ID: 9062374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desipramine for the treatment of "pure" dysthymia versus "double" depression.
    Marin DB; Kocsis JH; Frances AJ; Parides M
    Am J Psychiatry; 1994 Jul; 151(7):1079-80. PubMed ID: 8010368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.
    Barrett JE; Williams JW; Oxman TE; Frank E; Katon W; Sullivan M; Hegel MT; Cornell JE; Sengupta AS
    J Fam Pract; 2001 May; 50(5):405-12. PubMed ID: 11350703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline effects in adolescent major depression and dysthymia: a six-month open trial.
    Nixon MK; Milin R; Simeon JG; Cloutier P; Spenst W
    J Child Adolesc Psychopharmacol; 2001; 11(2):131-42. PubMed ID: 11436952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
    Haykal RF; Akiskal HS
    J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
    Amore M; Jori MC;
    Int Clin Psychopharmacol; 2001 Nov; 16(6):317-24. PubMed ID: 11712619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family study of early-onset dysthymia. Mood and personality disorders in relatives of outpatients with dysthymia and episodic major depression and normal controls.
    Klein DN; Riso LP; Donaldson SK; Schwartz JE; Anderson RL; Ouimette PC; Lizardi H; Aronson TA
    Arch Gen Psychiatry; 1995 Jun; 52(6):487-96. PubMed ID: 7771919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia.
    Pini S; Cassano GB; Simonini E; Savino M; Russo A; Montgomery SA
    J Affect Disord; 1997 Feb; 42(2-3):145-53. PubMed ID: 9105956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
    Versiani M
    J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is dysthymia a different disorder in the elderly?
    Devanand DP; Nobler MS; Singer T; Kiersky JE; Turret N; Roose SP; Sackeim HA
    Am J Psychiatry; 1994 Nov; 151(11):1592-9. PubMed ID: 7943446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
    Simon GE; Heiligenstein JH; Grothaus L; Katon W; Revicki D
    J Clin Psychiatry; 1998 Feb; 59(2):49-55. PubMed ID: 9501885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dysthymia: a chronic illness and its treatment].
    Aschauer HN
    Wien Med Wochenschr; 1999; 149(18):503-10. PubMed ID: 10637954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of minor depression or dysthymia in primary care following a randomized controlled treatment.
    Oxman TE; Barrett JE; Sengupta A; Katon W; Williams JW; Frank E; Hegel M
    Gen Hosp Psychiatry; 2001; 23(6):301-10. PubMed ID: 11738460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.